mmpc-logo mmpc-logo
twitter-logo    bluesky-logo
| Create Account | login
Publication
EGFR-mediated macrophage activation promotes colitis-associated tumorigenesis.
Authors Hardbower DM, Coburn LA, Asim M, Singh K, Sierra JC, Barry DP, Gobert AP,
Piazuelo MB, Washington MK, Wilson KT
Submitted By Submitted Externally on 7/27/2017
Status Published
Journal Oncogene
Year 2017
Date Published 7/1/2017
Volume : Pages 36 : 3807 - 3819
PubMed Reference 28263971
Abstract Epidermal growth factor receptor (EGFR) signaling is a known mediator of
colorectal carcinogenesis. Studies have focused on the role of EGFR signaling in
epithelial cells, although the exact nature of the role of EGFR in colorectal
carcinogenesis remains a topic of debate. Here, we present evidence that EGFR
signaling in myeloid cells, specifically macrophages, is critical for colon
tumorigenesis in the azoxymethane-dextran sodium sulfate (AOM-DSS) model of
colitis-associated carcinogenesis (CAC). In a human tissue microarray, colonic
macrophages demonstrated robust EGFR activation in the pre-cancerous stages of
colitis and dysplasia. Utilizing the AOM-DSS model, mice with a myeloid-specific
deletion of Egfr had significantly decreased tumor multiplicity and burden,
protection from high-grade dysplasia and significantly reduced colitis.
Intriguingly, mice with gastrointestinal epithelial cell-specific Egfr deletion
demonstrated no differences in tumorigenesis in the AOM-DSS model. The
alterations in tumorigenesis in myeloid-specific Egfr knockout mice were
accompanied by decreased macrophage, neutrophil and T-cell infiltration.
Pro-tumorigenic M2 macrophage activation was diminished in myeloid-specific
Egfr-deficient mice, as marked by decreased Arg1 and Il10 mRNA expression and
decreased interleukin (IL)-4, IL10 and IL-13 protein levels. Surprisingly,
diminished M1 macrophage activation was also detectable, as marked by
significantly reduced Nos2 and Il1b mRNA levels and decreased interferon
(IFN)-?, tumor necrosis factor (TNF)-a and IL-1ß protein levels. The alterations
in M1 and M2 macrophage activation were confirmed in bone marrow-derived
macrophages from mice with the myeloid-specific Egfr knockout. The combined
effect of restrained M1 and M2 macrophage activation resulted in decreased
production of pro-angiogenic factors, CXCL1 and vascular endothelial growth
factor (VEGF), and reduced CD31(+) blood vessels, which likely contributed to
protection from tumorigenesis. These data reveal that EGFR signaling in
macrophages, but not in colonic epithelial cells, has a significant role in CAC.
EGFR signaling in macrophages may prove to be an effective biomarker of CAC or
target for chemoprevention in patients with inflammatory bowel disease.




Menu

Home
Contact
About MMPC
Animal Husbandry
Tests Data
Search Data
Analysis
Clients
MMPC Centers

Newsletter

Interested in receiving MMPC News?
twitter-logo Mouse Phenotyping
@NationalMMPC



2017 National MMPC. All Rights Reserved.